Adagene Revenue

In the year 2025, Adagene had annual revenue of $7.67M with 7,332.75% growth. Adagene had revenue of $7.67M in the half year ending December 31, 2025, with 840.35% growth.

Revenue (ttm)

$7.67M

Revenue Growth

+7,332.75%

P/S Ratio

30.23

Revenue / Employee

$59,929

Employees

128

Market Cap

233.24M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.67M	7.57M	7,332.75%
Dec 31, 2024	103.20K	-18.01M	-99.43%
Dec 31, 2023	18.11M	8.82M	94.90%
Dec 31, 2022	9.29M	-882.58K	-8.67%
Dec 31, 2021	10.18M	9.47M	1,351.72%
Dec 31, 2020	700.91K	220.91K	46.02%
Dec 31, 2019	480.00K	-1.03M	-68.24%
Dec 31, 2018	1.51M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Fulcrum Therapeutics	80.00M
Cellectis	75.11M
Invivyd	55.87M
Orchestra BioMed Holdings	32.72M
Foghorn Therapeutics	28.22M
Sol-Gel Technologies	18.47M
Entrada Therapeutics	5.74M
AC Immune	4.62M

Revenue Rankings

ADAG News

4 weeks ago - Adagene Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
4 weeks ago - Adagene Slides: Investor presentation - Filings
5 weeks ago - Adagene to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
2 months ago - Adagene presents data from two Phase 1b/2 studies of muzastotug at AACR - TheFly
2 months ago - Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug's Potential as a Backbone Combination Therapy for Multiple Tumor Types - GlobeNewsWire
2 months ago - Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board - GlobeNewsWire
2 months ago - Adagene price target raised to $10 from $9 at Guggenheim - TheFly
2 months ago - Adagene Slides: Investor presentation - Filings

More News